Overview
Description
Recursion Pharmaceuticals Inc. is a biotechnology company that focuses on harnessing advanced computational biology and machine learning techniques to transform drug discovery processes. Founded in 2013 and headquartered in Salt Lake City, Utah, the company aims to accelerate the pace of pharmaceutical research and development by integrating automation, artificial intelligence, and biological sciences. By developing a platform that analyzes cellular imaging data, Recursion Pharmaceuticals Inc. seeks to identify novel treatments across a broad range of therapeutic areas, including oncology, fibrosis, and rare genetic diseases. The company's innovative approach has the potential to impact various healthcare sectors, addressing unmet medical needs and optimizing the drug development pipeline. As a player in the growing biotech industry, Recursion Pharmaceuticals Inc. is positioned at the intersection of technology and life sciences, striving to advance medical research and improve patient outcomes through cutting-edge scientific methodologies.
About
CEO
Dr. Christopher C. Gibson Ph.D.
Employees
800
Address
41 South Rio Grande Street
Salt Lake City, 84101, UT
United States
Salt Lake City, 84101, UT
United States
Phone
385 269 0203
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
Mexico
MIC code
XMEX